Search Results 8511-8520 of 42511 for oral

  1. Aditya Raghunathan, M.D., M.P.H. - Doctors and Medical Staff - Mayo Clinic

    Best Oral Presentation – Peripheral Nerve/ Basic Science/ General Spine35th Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves.

  2. Mayo Clinic Q & A

    Mayo Clinic Q&A: Understanding surgical options for oral cancer featured image. Mayo Clinic Q&A: Understanding surgical options for oral cancer. Chloe Corey.

  3. Publications - Stephen F. Bansberg, M.D. - Mayo Clinic

    High-grade carcinoma of the oral cavity. Otolaryngol Head Neck Surg. 1989 Jan; 100 (1):41-8. View PubMed; Bansberg SF, Harner SG, Forbes G. Relationship of ...

  4. Roxana S. Dronca, M.D. - Doctors and Medical Staff - Mayo Clinic

    3rd Place Oral Presentation AwardMichigan Chapter, American College of Physicians. 2003. Training AwardKaplan Medical Honor Society. 1994. Year 3-4 HonorsIuliu ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  8. Publications - Danesh K. Kella, M.B.B.S. - Mayo Clinic

    ... oral anticoagulants. J Interv Card Electrophysiol. 2019 Jan; 54 (1):81-89 Epub 2018 Sept 19. View PubMed; Isath A, Padmanabhan D, Naksuk N, Kella D, Friedman ...

  9. A Rollover Study To Further Evaluate The Safety And Efficacy Of Palovarotene Capsules In Male And Female Participants Aged ≥ 14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed The Relevant Parent Studies. - Mayo Clinic

    of these products during palovarotene treatment. - Exposure to synthetic oral retinoids other than palovarotene within 4 weeks of the. Inclusion Visit ...

  10. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors - Mayo Clinic

    oral TNG908 6. Active prior or concurrent malignancy. 7. Central nervous system metastases associated with progressive neurological symptoms 8. Current ...